Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.72 | 15.93 |
| PEG Ratio (TTM) | -1.24 | 2.13 |
| P/S Ratio (TTM) | 2.62 | 1.68 |
| P/B Ratio (TTM) | 2.31 | 3.09 |
| P/FCF Ratio (TTM) | -16.57 | 11.15 |
| Price to 5YR AVG Earnings Ratio | N/A | 1.24 |
| Price to 5YR AVG FCF Ratio | N/A | 32.92 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.12% | 7.52% |
| ROE (TTM) | 8.04% | 17.66% |
| Net Profit Margin (TTM) | 8.78% | 9.27% |
| ROIC 5YR AVG | N/A | 6.25% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -31.55% | 1,691.85% | N/A |
| Revenue | 20.29% | 87.14% | N/A |
| Net Income | -30.47% | 1,694.17% | N/A |
| Cash Flow | 23.08% | 326.95% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.23 | 1.84 |
| Quick Ratio (TTM) | 1.08 | 1.32 |
| D/E Ratio (TTM) | 0.45 | 1.10 |
| Interest Coverage (TTM) | 4.63 | 16.52 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 2.29 | 2.92 |
| LTL to 5YR AVG FCF | N/A | 7.96 |
| Shares Outstanding Growth 5YR AVG | N/A | 6.67% |